Isolation and molecular characterization of RcSERK1: A Rosa canina gene transcriptionally induced during initiation of protocorm-like bodies

A somatic embryogensis receptor-like kinase (SERK) gene was isolated from protocorm-like bodies (PLBs) of Rosa canina by a rapid amplification of cDNA ends (RACE) approach and was designated as RcSERK1. The RcSERK1 encodes a protein of 626 amino acid residues with a calculated molecular mass of 68.79 kDa and theoretical isoelectric point of 5.65. The amino acid sequence of RcSERK1 shares all the characteristic features of a SERK protein, including the signal peptide (SP), the leucine zipper (LZ), the five leucine-rich repeats (LRRs), the pro-rich domain containing the so-called Ser-Pro- Pro (SPP) motif, the transmembrane domain (TM), the kinase domain and the C-terminal domain. The transcripts of RcSERK1 were more enriched in PLBs than in rhizoids and callus, but not detected in leaflets (incubated under dark and before producing callus) and the regenerated shoots. Subcellular localization indicated that the fluorescence of RcSERK1-GFP was recorded in the plasma membrane. We argue that RcSERK1 is a Leu-rich repeat receptor-like kinase (LRR-RLK) and plasma  membrane localization protein.Keywords: somatic embryogensis receptor-like kinase (SERK)1, protocorm-like bodies (PLBs), Rosa canina, RACE, RcSERK1

Аналіз маркетингових підходів до збільшення продажів

Сучасний соціально-економічний стан у країні, невпинне зростання цін, посилення конкуренції в усіх сферах народного господарства, нестабільність політичних відносин тощо стали вагомими причинами зниження попиту багатьох товарів на ринку. Продати що-небудь у ситуації, що склалася, стає під силу далеко не кожному, будь то велика компанія, чи невеличке приватне підприємство. Проте інстинкт виживання диктує свої умови, при яких будь-який успішний продавець має свої секрети успішних продажів. Безумовно, що такий набір секретів не є догмою чи кліше для будь-якої ситуації. Кожен із цих секретів стикається особливостями та проблемами, що змушує оперативно шукати шляхи позитивного вирішення навіть в екстремальних ситуаціях

Defining the causes of sporadic Parkinson's disease in the global Parkinson's genetics program (GP2)

The Global Parkinson’s Genetics Program (GP2) will genotype over 150,000 participants from around the world, and integrate genetic and clinical data for use in large-scale analyses to dramatically expand our understanding of the genetic architecture of PD. This report details the workflow for cohort integration into the complex arm of GP2, and together with our outline of the monogenic hub in a companion paper, provides a generalizable blueprint for establishing large scale collaborative research consortia

Multi-ancestry genome-wide association meta-analysis of Parkinson?s disease

Although over 90 independent risk variants have been identified for Parkinson’s disease using genome-wide association studies, most studies have been performed in just one population at a time. Here we performed a large-scale multi-ancestry meta-analysis of Parkinson’s disease with 49,049 cases, 18,785 proxy cases and 2,458,063 controls including individuals of European, East Asian, Latin American and African ancestry. In a meta-analysis, we identified 78 independent genome-wide significant loci, including 12 potentially novel loci (MTF2, PIK3CA, ADD1, SYBU, IRS2, USP8, PIGL, FASN, MYLK2, USP25, EP300 and PPP6R2) and fine-mapped 6 putative causal variants at 6 known PD loci. By combining our results with publicly available eQTL data, we identified 25 putative risk genes in these novel loci whose expression is associated with PD risk. This work lays the groundwork for future efforts aimed at identifying PD loci in non-European populations